Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fluticasone Furoate UD-DPI vs ELLIPTA in Healthy Volunteers
NCT02218723Phase 1Completed
- Sponsor
- GSK
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fluticasone in asthma (10 arms), sponsored by GSK. Primary endpoints: Area Under the Plasma Concentration-Time Curve from Time Zero to 24 Hours, Area Under the Plasma Concentration-Time Curve from Time Zero Extrapolated to Infinite Time at Day 3 and 1 more. Started Oct 2014; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02218723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218723.